Results 231 to 240 of about 81,187 (302)

Correction to: Inflammation's impact on the interaction between oligodendrocytes and axons. [PDF]

Discov Immunol
europepmc   +1 more source

Brain-wide mapping of oligodendrocyte organization, oligodendrogenesis, and myelin injury. [PDF]

Cell
Xu YKT, Bush A, Musheyev E, Umans J, Zhang L, Kim AA, Zhang S, Eugenin von Bernhardi J, Yan Y, Sulam J, Bergles DE.   +10 more
europepmc   +1 more source

Quantitative MRI Biomarkers of Myelin: Cross‐Validation and Diagnostic Performance in Multiple Sclerosis

NMR in Biomedicine, Volume 39, Issue 7, July 2026.
STAIR‐UTE, STAIR‐STE, and MT‐derived myelin biomarkers (MPF, MWF, MMF, MTR) strongly correlate in WM, gray matter, and MS lesions. All distinguish normal from abnormal tissue, though subtle differences suggest complementary information. Histological validation is needed to confirm specificity.
James Lo, Nathan Chan, Dylan Tran, Jiyo S. Athertya, Mohammadamin Cheraghi, Soo Hyun Shin, Graeme M. Bydder, Yajun Ma   +7 more
wiley   +1 more source

The Flavonoid Apigenin Modulates Oligodendroglial Plasticity and Has a Neuroprotective Effect in Cerebellar Slice Cultures with Oxygen Glucose Deprivation. [PDF]

Nutrients
Carreira RB, Dos Santos CC, de Oliveira JVR, Silva NN, Silva VDAD, Victor MM, Butt AM, Costa SL.   +7 more
europepmc   +1 more source

Endothelial Netrin‐4 regulates oligodendrocyte precursor cell proliferation and differentiation via ET‐1 signaling in preterm white matter injury

Brain Pathology, Volume 36, Issue 4, July 2026.
Our findings show early increased Netrin‐4 in mice with PWMI boosts angiogenesis and OPCs proliferation. Later, high levels hinder OPCs differentiation into mature cells, impairing myelination. It may act by stimulating ET‐1 secretion. Abstract Perinatal hypoxia–ischemia is a leading cause of preterm white matter injury (PWMI), yet mechanisms ...
Fuxing Dong, Weixing Yan, Qiqi Meng, Xueli Song, Bing Cheng, Yaping Liu, Yanan Liu, Chao Ren, Ruiqin Yao   +8 more
wiley   +1 more source

DNAJC6 Parkinson's disease: Endolysosomal dysfunction and emerging roles for oligodendrocytes. [PDF]

NPJ Parkinsons Dis
Allen AG, Stednitz S, Lardelli M, Barthelson K.   +3 more
europepmc   +1 more source

Optic nerve sheath meningioma exhibits neural niche‐associated transcriptomic features and rare copy number variation‐linked evolution

Brain Pathology, Volume 36, Issue 4, July 2026.
Optic nerve sheath meningiomas are typically NF2‐intact with few copy number alterations and are generally clinically indolent. Rare aggressive recurrences are associated with progressive accumulation of copy number variations, including CDKN2A/B homozygous deletion, 1q gain, and 14q loss.
Daisuke Sato, Satoru Miyawaki, Yu Sakai, Kenta Ohara, Yu Teranishi, Yudai Hirano, Motoyuki Umekawa, Takahiro Tsuchiya, Shotaro Ogawa, So Hirata, Hiroki Hongo, Hideaki Ono, Daisuke Komura, Tetsuo Ushiku, Shumpei Ishikawa, Nobuhito Saito   +15 more
wiley   +1 more source

Impaired myelination in multiple sclerosis organoids: p21 links oligodendrocyte dysfunction to disease subtype. [PDF]

Front Cell Neurosci
Sadiq SA, Mehta T, Holzman W, McDermott A, Daviaud N.   +4 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, Volume 20, Issue 6, Page 1398-1419, June 2026.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Human Myelin Spheres for in Vitro Oligodendrocyte Maturation, Myelination and Neurological Disease Modeling. [PDF]

Stem Cell Rev Rep
Ahuja K, Ramezankhani R, Wang X, Burg T, Amos G, Neyrinck K, Silva A, Arekatla G, Cassidy EE, Nami F, Terryn J, Wierda K, Vints K, Vandamme N, Poovathingal S, Lambrichts I, Swinnen JV, Van Den Bosch L, De Groef L, Moons L, Verfaillie C, Neyts J, Jochmans D, Chai YC.   +23 more
europepmc   +1 more source